Joaquim Calado

MD, PhD

Invited Assistant Professor, NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
Centre for Toxicogenomics and Human Health (ToxOmics)

https://orcid.org/0000-0002-1194-3392

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education/Academic qualification

Ciências da Saúde -Genética, Doctorate, NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)

Award Date: 1 Jul 2001

Ciências da Saúde - Medicina, Master, Universidade de Lisboa

Award Date: 1 Jul 1987

Fingerprint

Dive into the research topics where Joaquim Calado is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

9 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

908 Citations
12 h-Index
15 Article
2 Review article
1 Other contribution

Genetic and Clinical Predictors of Age of ESKD in Individuals With Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutations
Kidd, K., Vylet'al, P., Schaeffer, C., Olinger, E., Živná, M., Hodaňová, K., Robins, V., Johnson, E., Taylor, A., Martin, L., Izzi, C., Jorge, S. C., Calado, J., Torres, R. J., Lhotta, K., Steubl, D., Gale, D. P., Gast, C., Gombos, E., Ainsworth, H. C. & 22 others, Chen, Y. M., Almeida, J. R., de Souza, C. F., Silveira, C., Raposeiro, R., Weller, N., Conlon, P. J., Murray, S. L., Benson, K. A., Cavalleri, G. L., Votruba, M., Vrbacká, A., Amoroso, A., Gianchino, D., Caridi, G., Ghiggeri, G. M., Divers, J., Scolari, F., Devuyst, O., Rampoldi, L., Kmoch, S. & Bleyer, A. J., Sep 2020, In : Kidney International Reports. 5, 9, p. 1472-1485 14 p.
Research output: Contribution to journal › Article

Open Access
File
1 Citation (Scopus)

1 Downloads (Pure)
Efeito da empagliflozina para além do controlo glicémico: benefício cardiovascular em doentes com DMT2 e doença cardiovascular estabelecida
Monteiro, P., Aguiar, C., Matos, P., Silva‐Nunes, J., Birne, R., Branco, P., Calado, J., Melo, M. & Polónia, J., Oct 2019, In : Revista Portuguesa de Cardiologia. p. 721-735
Research output: Contribution to journal › Review article
1 Citation (Scopus)
1 Citation (Scopus)
MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2
Coady, M. J., El Tarazi, A., Santer, R., Bissonnette, P., Sasseville, L. J., Calado, J., Lussier, Y., Dumayne, C., Bichet, D. G. & Lapointe, J-Y., Jan 2017, In : Journal Of The American Society Of Nephrology. 28, 1, p. 85-93 8 p.
Research output: Contribution to journal › Article
28 Citations (Scopus)
Adult presentation of Bartter syndrome type IV with erythrocytosis
Heilberg, I. P. F., Tótoli, C. & Calado, J. T. O., 1 Oct 2015, In : Einstein (São Paulo, Brazil). 13, 4, p. 604-606 3 p.
Research output: Contribution to journal › Article

Open Access
File
9 Citations (Scopus)

4 Downloads (Pure)

Education/Academic qualification

Genetic and Clinical Predictors of Age of ESKD in Individuals With Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutations

Efeito da empagliflozina para além do controlo glicémico: benefício cardiovascular em doentes com DMT2 e doença cardiovascular estabelecida

MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2

Adult presentation of Bartter syndrome type IV with erythrocytosis